Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo
https://www.zacks.com/commentary/2288461/top-stock-reports-for-berkshire-hathaway-eli-lilly-pepsico?cid=CS-ZC-FT-research_daily-2288461
Jun 14, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Eli Lilly and Company (LLY) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks Hovnanian Enterprises, Inc. (HOV) and IDT Corporation (IDT).
0
5 Hot Growth Stocks: Buy on the Highs or Wait for a Pullback?
https://www.zacks.com/stock/news/2288059/5-hot-growth-stocks-buy-on-the-highs-or-wait-for-a-pullback?cid=CS-ZC-FT-market_edge-2288059
Jun 13, 2024 - These 5 stocks are red hot and hitting new all-time highs. Have you missed the trade?
0
Weight Loss Drugs: Are They Really Magic?
https://www.fool.com/investing/2024/06/13/weight-loss-drugs-are-they-really-magic/?source=iedfolrf0000001
Jun 13, 2024 - Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs."
0
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2287885/why-eli-lilly-lly-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2287885
Jun 13, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.
https://www.fool.com/investing/2024/06/13/get-richer-2-top-stocks-to-buy-now-and-hold/?source=iedfolrf0000001
Jun 13, 2024 - These proven wealth builders have what it takes to deliver solid gains long-term.
0
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
https://www.fool.com/investing/2024/06/12/a-life-expansion-revolution-is-coming-3-stocks-tha/?source=iedfolrf0000001
Jun 12, 2024 - The integration of AI and healthcare is well underway.
0
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
https://www.zacks.com/stock/news/2286691/structure-therapeutics-gpcr-rallying-on-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2286691
Jun 11, 2024 - Structure Therapeutics (GPCR) stock sees an upside on positive top-line data from a phase IIa obesity study as well as a capsule-to-tablet PK study on its obesity candidate, GSBR-1290.
0
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
https://www.zacks.com/stock/news/2285380/pharma-stock-roundup-lly-s-cfo-departs-abbv-azn-drugs-get-chmp-approval?cid=CS-ZC-FT-analyst_blog|stock_roundup-2285380
Jun 07, 2024 - Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
0
Eli Lilly (LLY) Veteran Anat Ashkenazi to Join Alphabet as CFO
https://www.zacks.com/stock/news/2284718/eli-lilly-lly-veteran-anat-ashkenazi-to-join-alphabet-as-cfo?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2284718
Jun 06, 2024 - Eli Lilly (LLY) CFO Anat Ashkenazi joins Google's parent company Alphabet as CFO and senior vice president, effective from Jul 31, 2024
0
ETFs to Profit from the Weight Loss Drug Boom
https://www.zacks.com/stock/news/2283455/etfs-to-profit-from-the-weight-loss-drug-boom?cid=CS-ZC-FT-etf_news_and_commentary-2283455
Jun 04, 2024 - The market for GLP-1 drugs could soar to $130 billion by 2030
0